The RSVpreF vaccine demonstrated 91% effectiveness against RSV-related lower respiratory tract disease in older adults during ...

Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

Thurston County has recorded its first influenza-related death for the 2024-2025 flu season, according to a Friday news release. The county learned about the death as the state is ...

Respiratory illnesses are on the rise, but there are ways to prevent the spread. Rhode Island's Department of Health has ...

Amid rising concerns over an outbreak of Human Metapneumovirus (HMPV) in China, the Union Health Ministry announced on Friday ...

HMPV causes respiratory infections with symptoms like cough, fever, and pneumonia. It spreads through droplets and close contact, with prevention involving hygiene practices and symptom management.

The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...

Prevention remains key While there are no vaccines or antiviral treatments for HMPV, Dr Jayadevan recommended simple ...

NHS England said as of 29 December, there were 87 flu patients at the Royal Devon and Exeter Hospital along with 32 at the ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...

COVID-19 activity is increasing in most regions, with test positivity rising to 7.1%. Emergency department visits are also on the rise from previously low levels. The CDC anticipates continued ...